PAMELA MURRAY: Open Payments
NPI 1851608590 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,874 in 156 payments from 22 companies in 2025. Trend: 2023 $4,033 · 2024 $3,563 · 2025 $2,874
Food & beverage: $2,864Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $416 |
| Arcutis Biotherapeutics, Inc. | 16 | $291 |
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| Janssen Biotech, Inc. | 10 | $195 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $173 |
| Lilly USA, LLC | 7 | $171 |
| UCB, Inc. | 6 | $157 |
| Organon LLC | 12 | $156 |
| LEO Pharma Inc. | 10 | $154 |
| Incyte Corporation | 8 | $149 |
Products named: Zoryve, SKYRIZI, TREMFYA, RINVOQ, TALTZ, Bimzelx, OPZELURA, OTEZLA.
Industry payments across TX — which companies pay providers there.
